These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 16723295)
41. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618 [TBL] [Abstract][Full Text] [Related]
42. Advances in prostanoid infusion therapy for pulmonary arterial hypertension. Doran A; Harris S; Goetz B J Infus Nurs; 2008; 31(6):336-45. PubMed ID: 19018187 [TBL] [Abstract][Full Text] [Related]
43. Diagnosis and management of primary pulmonary hypertension. Krishnan U Indian J Pediatr; 2000 Mar; 67(3 Suppl):S41-5. PubMed ID: 11129920 [TBL] [Abstract][Full Text] [Related]
44. Pulmonary hypertension in infancy and childhood. Gorenflo M; Nelle M; Schnabe PA; Ullmann MV Cardiol Young; 2003 Jun; 13(3):219-27. PubMed ID: 12903868 [TBL] [Abstract][Full Text] [Related]
45. Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease. Zaidi AN; Dettorre MD; Ceneviva GD; Thomas NJ Pediatr Pulmonol; 2005 Sep; 40(3):265-9. PubMed ID: 15830393 [TBL] [Abstract][Full Text] [Related]
46. [Adenosine for pulmonary vasodilator testing in children with idiopathic pulmonary arterial hypertension]. Fu LJ; Zhou AQ; Guo Y; Zhao PJ; Huang MR; Li F Zhonghua Er Ke Za Zhi; 2011 Dec; 49(12):886-9. PubMed ID: 22336352 [TBL] [Abstract][Full Text] [Related]
47. [Clinical characteristics of 161 Chinese patients with idiopathic pulmonary arterial hypertension]. Jia WB; Jiang X; Zuo XR; He J; Zhao QH; Jiang R; Jing ZC Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Aug; 40(8):652-6. PubMed ID: 23141008 [TBL] [Abstract][Full Text] [Related]
53. [Gene therapy and cell therapy for idiopathic pulmonary arterial hypertension]. Takemiya K; Kai H; Imaizumi T Nihon Rinsho; 2008 Nov; 66(11):2187-92. PubMed ID: 19051741 [TBL] [Abstract][Full Text] [Related]
54. Pharmacotherapy of chronic pulmonary arterial hypertension: value and limitations. Part I: Primary pulmonary hypertension. Alpert MA; Concannon MD; Mukerji B; Mukerji V Angiology; 1994 Aug; 45(8):667-76. PubMed ID: 7914075 [TBL] [Abstract][Full Text] [Related]
55. Paediatric pulmonary vascular disease. Lang IM; Bonderman D; Kneussl M; Marx M Paediatr Respir Rev; 2004 Sep; 5(3):238-48. PubMed ID: 15276136 [TBL] [Abstract][Full Text] [Related]
56. [Effect of lung resection on the decrease of hypertension in the pulmonary artery by means of drugs]. Lenz J; Hartel W; Schuster G; Kohlhepp E Thoraxchir Vask Chir; 1970 Feb; 18(1):27-33. PubMed ID: 5265955 [No Abstract] [Full Text] [Related]
57. [The respiratory system im chronic pyelonephritis]. Larina TA Klin Med (Mosk); 2003; 81(3):36-9. PubMed ID: 12698849 [TBL] [Abstract][Full Text] [Related]
58. Possible therapeutic use of vasodilator iontophoresis. Murray AK; Herrick AL; Gorodkin RE; Moore TL; King TA Microvasc Res; 2005 Jan; 69(1-2):89-94. PubMed ID: 15797265 [TBL] [Abstract][Full Text] [Related]
60. [Front line of molecular biological study on and therapy for pulmonary hypertension]. Kuriyama T Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1676-90. PubMed ID: 17037300 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]